| Mapping genomic loci implicates genes and synaptic biology in schizophrenia V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ... Nature 604 (7906), 502-508, 2022 | 1303 | 2022 |
| Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis C Noto, VK Ota, ES Gouvea, LB Rizzo, LMN Spindola, PHS Honda, ... International Journal of Neuropsychopharmacology 18 (4), pyu042, 2015 | 136 | 2015 |
| Early life adversity, genomic plasticity, and psychopathology G Turecki, VK Ota, SI Belangero, A Jackowski, J Kaufman The Lancet Psychiatry 1 (6), 461-466, 2014 | 131 | 2014 |
| High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance C Noto, M Maes, VK Ota, AL Teixeira, RA Bressan, A Gadelha, E Brietzke The World Journal of Biological Psychiatry 16 (6), 422-429, 2015 | 101 | 2015 |
| Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis MN Noto, M Maes, SOV Nunes, VK Ota, AC Rossaneis, WA Verri Jr, ... European Neuropsychopharmacology 29 (3), 416-431, 2019 | 83 | 2019 |
| Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone C Noto, VK Ota, A Gadelha, MN Noto, DS Barbosa, KL Bonifácio, ... Journal of psychiatric research 68, 210-216, 2015 | 78 | 2015 |
| Effects of depression on the cytokine profile in drug naive first-episode psychosis C Noto, VK Ota, ML Santoro, BB Ortiz, LB Rizzo, CH Higuchi, Q Cordeiro, ... Schizophrenia research 164 (1-3), 53-58, 2015 | 73 | 2015 |
| Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic naïve first episode psychosis C Noto, VK Ota, ML Santoro, ES Gouvea, PN Silva, LM Spindola, ... Molecular neurobiology 53 (8), 5701-5709, 2016 | 71 | 2016 |
| Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia A Zugman, A Gadelha, I Assunção, J Sato, VK Ota, DL Rocha, JJ Mari, ... Schizophrenia research 148 (1-3), 81-86, 2013 | 70 | 2013 |
| Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia E Asevedo, LB Rizzo, A Gadelha, RB Mansur, VK Ota, AA Berberian, ... Physiology & behavior 129, 194-198, 2014 | 64 | 2014 |
| Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort ML Santoro, V Ota, S de Jong, C Noto, LM Spindola, F Talarico, E Gouvea, ... Translational psychiatry 8 (1), 174, 2018 | 63 | 2018 |
| Implication of LRRC4C and DPP6 in neurodevelopmental disorders G Maussion, C Cruceanu, JA Rosenfeld, SC Bell, F Jollant, J Szatkiewicz, ... American Journal of Medical Genetics Part A 173 (2), 395-406, 2017 | 50 | 2017 |
| DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs VK Ota, LN Spíndola, A Gadelha, AF dos Santos Filho, ML Santoro, ... Schizophrenia research 142 (1-3), 206-208, 2012 | 44 | 2012 |
| Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis FF Brinholi, C Noto, M Maes, KL Bonifácio, E Brietzke, VK Ota, A Gadelha, ... Schizophrenia research 166 (1-3), 225-230, 2015 | 43 | 2015 |
| Changes in gene expression and methylation in the blood of patients with first-episode psychosis VK Ota, C Noto, A Gadelha, ML Santoro, LM Spindola, ES Gouvea, ... Schizophrenia research 159 (2-3), 358-364, 2014 | 43 | 2014 |
| Vascular loops in the anterior inferior cerebellar artery, as identified by magnetic resonance imaging, and their relationship with otologic symptoms L Abreu, CH Kuniyoshi, AB Wolosker, ML Borri, A Antunes, VKA Ota, ... Radiologia Brasileira 49 (5), 300-304, 2016 | 41 | 2016 |
| Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls CT Matsuzaka, D Christofolini, VK Ota, A Gadelha, AA Berberian, C Noto, ... Revista Brasileira de Psiquiatria 39 (4), 302-308, 2017 | 38 | 2017 |
| Accessing gene expression in treatment-resistant schizophrenia PN Moretti, VK Ota, ES Gouvea, M Pedrini, ML Santoro, F Talarico, ... Molecular neurobiology 55, 7000-7008, 2018 | 33 | 2018 |
| A molecular model for neurodevelopmental disorders CO Gigek, ES Chen, VK Ota, G Maussion, H Peng, K Vaillancourt, ... Translational psychiatry 5 (5), e565-e565, 2015 | 30 | 2015 |
| A systematic review on the effects of social discrimination on telomere length BM Coimbra, CM Carvalho, VK Ota, T Vieira-Fonseca, A Bugiga, AF Mello, ... Psychoneuroendocrinology 120, 104766, 2020 | 29 | 2020 |
Jair MariUniversidade Federal de São Paulo在 unifesp.br 的电子邮件经过验证
